View in EDS HTML Full Text PDF Full Text

Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.

Saved in:
Bibliographic Details
Title: Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.
Authors: Otsuka F; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Rasmussen MH; Clinical Drug Development, Novo Nordisk A/S, Søborg, Denmark., Endo T; Medical Affairs Department, Novo Nordisk Pharma Ltd., Tokyo, Japan., Sværke C; Clinical Drug Development, Novo Nordisk A/S, Søborg, Denmark., Tahara S; Department of Neurological Surgery, Nippon Medical School, Musashikosugi Hospital, Kawasaki City, Kanagawa, Japan., Johannsson G; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg and Department of Endocrinology, Diabetology, and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2025 Feb 07; Vol. 16, pp. 1534891. Date of Electronic Publication: 2025 Feb 07 (Print Publication: 2025).
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase I
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39991735
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Otsuka+F%22">Otsuka F</searchLink>; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Rasmussen+MH%22">Rasmussen MH</searchLink>; Clinical Drug Development, Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Endo+T%22">Endo T</searchLink>; Medical Affairs Department, Novo Nordisk Pharma Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sværke+C%22">Sværke C</searchLink>; Clinical Drug Development, Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Tahara+S%22">Tahara S</searchLink>; Department of Neurological Surgery, Nippon Medical School, Musashikosugi Hospital, Kawasaki City, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Johannsson+G%22">Johannsson G</searchLink>; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg and Department of Endocrinology, Diabetology, and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101555782%22">Frontiers in endocrinology</searchLink> [Front Endocrinol (Lausanne)] 2025 Feb 07; Vol. 16, pp. 1534891. <i>Date of Electronic Publication: </i>2025 Feb 07 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101555782 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-2392 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216642392%22">16642392 </searchLink><i>NLM ISO Abbreviation: </i>Front Endocrinol (Lausanne) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39991735
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fendo.2025.1534891
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1534891
    Titles:
      – TitleFull: Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Otsuka F
      – PersonEntity:
          Name:
            NameFull: Rasmussen MH
      – PersonEntity:
          Name:
            NameFull: Endo T
      – PersonEntity:
          Name:
            NameFull: Sværke C
      – PersonEntity:
          Name:
            NameFull: Tahara S
      – PersonEntity:
          Name:
            NameFull: Johannsson G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 02
              Text: 2025 Feb 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1664-2392
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in endocrinology
              Type: main
ResultId 1